Australia markets closed

Bionomics Limited (BNO.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.19000.0000 (0.00%)
At close: 4:10PM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 5187.43M
Enterprise value 3143.66M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)85.42
Price/book (mrq)8.64
Enterprise value/revenue 365.48
Enterprise value/EBITDA 7-23.49

Trading information

Stock price history

Beta (5Y monthly) 2.86
52-week change 3303.17%
S&P500 52-week change 348.25%
52-week high 30.4850
52-week low 30.0386
50-day moving average 30.2403
200-day moving average 30.1766

Share statistics

Avg vol (3-month) 32.17M
Avg vol (10-day) 31.25M
Shares outstanding 5986.46M
Implied shares outstanding 6N/A
Float 489.31M
% held by insiders 13.78%
% held by institutions 127.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 302 Mar 2004

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin -19.66%
Operating margin (ttm)-343.13%

Management effectiveness

Return on assets (ttm)-12.67%
Return on equity (ttm)4.93%

Income statement

Revenue (ttm)2.19M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-58.60%
Gross profit (ttm)-2.64M
EBITDA -6.11M
Net income avi to common (ttm)675.09k
Diluted EPS (ttm)-0.0010
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.74M
Total cash per share (mrq)0.01
Total debt (mrq)9.7M
Total debt/equity (mrq)60.34
Current ratio (mrq)0.74
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-5.09M
Levered free cash flow (ttm)-727.29k